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Abstract 
 
Purpose. The purpose of this study was to evaluate hypoesthesia of the upper lip and bone 
formation using self-setting α-tricalcium phosphate (Biopex®) between the segments 
following Le Fort I osteotomy with bent absorbable plate fixation.  
Subjects and Methods. The subjects were 47 patients (94 sides) who underwent Le Fort I 
osteotomy with and without mandibular osteotomy. They were divided into a Biopex® 
group (48 sides) and a control group (46 sides). The Biopex® was inserted into the anterior 
part of the gap between the segments in the Biopex® group. Trigeminal nerve hypoesthesia 
at the region of the upper lip was assessed bilaterally by the trigeminal 
somatosensory-evoked potential (TSEP) method. The area of the Biopex® at the anterior 
part in the maxilla was assessed immediately after surgery and 1 year postoperatively by 
computed tomography (CT).  
Results. The mean measurable period and standard deviation were 13.2±18.5 weeks in the 
control group, 14.5±17.9 weeks in the Biopex® group, and there was no significant 
difference in TSEP. The area of the Biopex® after 1 year was significantly smaller than 
that immediately after surgery (right side: P=0.0024, left side: P=0.0001) and bone defects 
between the segments could not be found in the Biopex® group. In the control group, 
although the areas of bone defect after 1 year were significantly smaller than that 
immediately after surgery on the right side (P=0.0133) and left side (P=0.0469) in the 
frontal view, complete healing of the bone defects could be seen in 12 of 46 sides after 1 
year.   
Conclusion. This study suggested that inserting Biopex® in the gap between the maxillary 
segments was useful for new bone formation and it did not prevent the recovery of upper 
lip hypoesthesia after Le Fort I osteotomy with absorbable plate fixation.  
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Introduction  
 
Our previous study showed that bony healing could occur in spaces between the 
segments of the maxilla and pterygomaxillary regions as well as the region of the anterior 
and lateral walls in the maxilla, but it is not always complete within 1 year after Le Fort I 
osteotomy (Ueki et al., 2011). To obtain long-term stability, use of various alternative 
materials between the segments should be considered. Autogenous bone from the iliac crest 
or rib has been recommended (Araujo et al., 1978; Bloomquist, 1980; Bloomquist, 1982), 
although freeze dried bone (Epker et al., 1976), proplast blocks (Burton et al., 1980), and 
the solid-block form of hydroxy apatite have also been advocated (Kent et al., 1986).     
Self-setting α-tricalcium phosphate (Biopex®) (Pentax Co, Tokyo, Japan) has also been 
recognized as one of the very useful bone alternative materials (Manma et al., 1988; Ueki et 
al., 2011), and has been used in Japan.  
Recently, an absorbable fixation plate system (Super-FIXSORB®-MX. Takiron Co. Ltd, 
Osaka) was newly developed for use in orthopedic or cranio-facial, oral and maxillofacial 
or plastic and reconstructive surgeries (Shikinami & Okuno, 1999; Shikinami & Okuno, 
2001; Shikinami et al, 2005). The previous study suggested that there were no significant 
differences in the postoperative time-course changes among the u-HA/PLLA plate system, 
PLLA plate system and conventional titanium plate system in orthognathic surgery (Ueki et 
al, 2011b). Moure et al (2012) also reported that the bimaxillary orthognathic procedure 
with bioresorbable osteosynthesis is a reliable and reproducible method in Angle Class III 
malocclusions. However, when the absorbable plate system was used in cases where the 
space between the bony segments was wide, whether proper rigidity and stability can be 
achieved was also considered.  Therefore, the combined use of segmental fixation with an 
absorbable plate system and filling in the space between the segments were assumed to be 
clinically necessary. 
On the other hand, disturbance of the sensitivity of the upper lip should be considered 
after Le Fort I osteotomy with some materials. One year postoperatively a partial to total 
recovery of sensation of the affected area has been reported (Nelson et al., 1977; de Jongh 
et al., 1986; Kahnberg and Emgströn, 1987).  The previous study objectively showed that 
hypoesthesia occurs in the upper lip following Le Fort I osteotomy with (trigeminal 
somatosensory-evoked potential) TSEP (Ueki et al, 2007). When the alternative materials 
are used at the area between the maxillary segments, it is unclear whether the recovery 
period of the upper lip hypoesthesia can be delayed. 
The purpose of this study was to evaluate hypoesthesia of the upper lip with TSEP and 
bone formation using self-setting α-tricalcium phosphate (Biopex®) between the maxillary 
segments after Le Fort I osteotomy with bent absorbable plate fixation. 
 
Patients and Methods 
Patients 
Forty seven Japanese adults (men: 18, women: 29) in this study presented with jaw 
deformities diagnosed as mandibular prognathism with and without maxillary deformity. At 
the time of orthognathic surgery, the patients ranged in age from 16 to 48 years, with a 
mean age of 26.1years (standard deviation, 7.5 years). Informed consent was obtained from 
the patients and the study was approved by Kanazawa University Hospital.  
 
Surgery  
The patients were divided into a Biopex® group (24 cases, 48 sides) and a control group 
(23 cases, 46 sides). In the Biopex® group, 22 of 24 patients underwent Le Fort I 
osteotomy and bilateral sagittal split ramus osteotomy (SSRO), 2 patients underwent Le 
Fort I osteotomy alone. In the control group, 20 of 23 patients underwent Le Fort I 
osteotomy with bilateral SSRO, two patients underwent Le Fort I osteotomy with SSRO for 
one side and intraoral vertical ramus osteotomy (IVRO) for the other side and one patient 
underwent Le Fort I osteotomy with bilateral IVRO.  
All patients underwent a standard Le Fort I osteotomy following a periodontal 
incision at the anterior teeth and a vestibular incision at the posterior teeth to prevent any 
postoperative scar at the labial gingival tissue, with inter-maxillary fixation screws (Jeil 
Medical, Seoul, Korea) implanted in the bimaxillary anterior alveolar bone, according to 
the previous report (Ueki et al., 2004; Ueki et al., 2009). Two L-type titanium plates at the 
site of the piriform rim, two straight titanium plates at the site of the zygomatic buttress and 
screws (Universal Mid-face fixation module, Stryker, Freiburg, German) were used for four 
patients, Two L-type absorbable plates at the site of the piriform rim, two straight 
absorbable plates at the site of the zygomatic buttress and screws (uncalcined and 
unsintered hydroxyapatite and poly-L-lactic acid (uHA/PLLA): super FIXSORB®MX, 
Takiron Co. Ltd, Osaka, Japan) were used for all patients. Post-operative inter-maxillary 
fixation was not performed, but traction by elastic was performed in all cases. 
 
CT assessment 
The patients were placed in the gantry with the tragacanthal line perpendicular to the 
ground for CT scanning. They were instructed to breathe normally and to avoid swallowing 
during the scanning process. CT scans were obtained in the radiology department by skilled 
radiology technicians using a high-speed, advantage-type CT generator (Light Speed Plus; 
GE Healthcare, Milwaukee, WI, USA) with each sequence taken 1.25 mm apart for the 3D 
reconstruction (120 kV, average 150 mA, 0.7 sec/rotation, helical pitch 0.75). The 3D 
image was reconstructed by a 3D visualization and measurement software, Med View 
version 5.5 (LEXI Co, Tokyo, Japan). At 1 week after surgery and the 1 year follow up, CT 
scans were taken for all patients who underwent orthognathic surgery and gave their 
informed consent.   
 
Measurements using CT 
In the control group, the threshold of the CT value (Hounsfield units: HU) of the 
measurable maxillary bone was standardized as over 1200. The frontal (right and left) view 
perpendicular to the FH (Frankfurt) plane was reconstructed to measure the bone defect 
area between segments of the maxilla after Le Fort I osteotomy on the right and left sides 
(Fig. 1). A total of 46 sides (23 right and 23 left sides) were measured.  In the Biopex® 
group, the threshold of the CT value (Hounsfield units: HU) of the measurable maxillary 
bone was standardized as from 1200 to 2200 HU and the threshold of the measurable CT 
value of the Biopex® inserted at the maxilla was standard at over 2200. The 3D CT image 
from 1200 HU to 2200HU was treated at 80% transparency and superimposed on the image 
of the over 2200 HU. The area over 2200 HU was measured as Biopex® at the anterior area 
of the maxilla (Fig. 2). A total of 48 sides (24 right and 24 left sides) were measured. The 
defective area in the control group and the high density area in the Biopex group were 
measured in the frontal view (as 2 dimensional images) made from the 3D CT images using 
the image software（Scion image, Scion corporation ML, USA）and the Med View version 
5.5 (LEXI Co, Tokyo, Japan).  
All CT images were measured by an author (K.U.). Fifteen patients were selected and the 
calculation performed using Dahlberg’s formula (Dahlberg, 1940):  
            ME=√∑d2/2n 
Where d is the difference between 2 registrations of a pair, and n is the number of double 
registrations. The random errors did not exceed 0.21 mm for the linear measurements and 
2.0 mm2 for the square measurements. 
Trigeminal nerve hypoesthesia was assessed bilaterally by the TSEP method. The 
methodology and values of TSEP have been described previously in our preliminary 
studies (Nakagawa et al., 1997; Nakagawa et al., 2001; Nakagawa et al., 2003). The 
electrodes were placed exactly above the highest point of the vermilion border and on the 
mucosa of the upper lip. An electroencephalograph recording system (Neuropack Sigma™; 
Nihon Koden Corp., Tokyo, Japan) was used to measure the potentials. The right and left 
sides were measured separately so that a total of 94 sides could be assessed. Each patient 
was evaluated pre-operatively and then post-operatively at 1 and 2 weeks, 1, 3, 6 months, 1 
year and 1.5 years. The measurable period was determined as the time when TSEP was first 
measurable post-operatively. Measurement of TSEP after surgery was continued until it 
became measurable. 
Trigeminal hypoesthesia was assessed by the latency of P1 and N2 in the recorded TSEP 
spectra. An earlier pilot study in healthy volunteers showed that these peaks produced an 
accurate figure and tended to result in better reproducibility. Measurable periods of TSEP 
were defined as periods before the peaks of N1 (N13), P1 (P17), N2 (N27), and P2 (P36) 
that were identified clearly as early components of the TSEP wave. Actual data was 




Statistical analysis     
 
Data were statistically analyzed with StatView software, version 4.5 (ABACUS Concepts, 
Inc., Berkeley, CA, USA) and Dr. SPSSII (SPSS Japan Inc., Tokyo, Japan).  Differences 




No fracture was noted in the upper third of the pterygoid plates, and there was no fracture 
of the cranial base. Intended maxillary movement by simulation surgery could be achieved 
in all cases. Therefore, there was no difference between the intended maxillary movement 
and the actual post-operative maxillary movement. Blood loss was small and no patient 
required transfusion.  
At 1 year after surgery, the shape of the uHA/PLLA plate did not change in all cases. 
Therefore, the area of overlap between the bone defect and the plate was not included in the 
measurement of the area in the cases where the uHA/PLLA plates were used in the control 
group. 
In the control group, the results of the statistical analysis showed that the areas of bone 
defect after 1 year were significantly smaller than those immediately after surgery on the 
right side (p=0.0133) and left side in the frontal view (p=0.0469). After 1 year, complete 
bone continuity between segments could be recognized just in 5/23 sides on the right and 
7/23 sides on the left in the frontal view. However, the area of bone defect after 1 year was 
seen in 18 /23 sides on the right and 16/23 sides on the left in the frontal view (Fig.1A, 
Table. 1A).  
On the other hand, in the Biopex® group, the area of bone defect after 1 year could not be 
seen in all sides. The area of the Biopex® after 1 year was significantly smaller than that 
immediately after surgery (right side: P=0.0024, left side: P=0.0001), when the setting for 
Biopex® was considered as over 2200 HU in the CT image (Fig.1B, Table. 1B). 
In the control group, TSEP was measurable within 1 week in 16 of 46 (34.8%) sides of the 
upper lip, within 2 weeks in 22 sides (47.8%), within 1 month in 28 sides (60.9%), within 3 
months in 32 sides (69.6%), within 6 months in 42 sides (80.4%), within 1 year in42 sides 
(91.3%) and within 1.5 years in 44 sides (95.7%).  Pre- and postoperative measurements 
of TSEP were impossible in the remaining 2 sides in one patient.  
In the Biopex® group, TSEP was measurable within 1 week in 6 of 48 (12.5%) sides of the 
upper lip, within 2 weeks in 11 sides (22.9 %), within 1 month in 28 sides (58.3%), within 
3 months in 34 sides (70.8%), within 6 months in 41 sides (85.4%), within 1 year in 45 
sides (93.8%), and within 1.5 year in 48 sides (100%).   
In the latency period, the Biopex® group significantly showed a lower value than the 
control group preoperatively (N1; P=0.0145, P1; P=0.0332, N2; P=0.0295), however, there 
was no significant difference between the two groups postoperatively. The values in the 
post-operative measurable period were significantly longer than those in the pre-operative 
period in the latency period in N1, P1 and N2 in the control group (N1; P=0.0015, P1; 
P=0.0018, N2; P=0.0246), and in N1, P1, N2 and P2 in the Biopex® group (N1; P<0.0001, 
P1; P<0.0001, N2; P<0.0001, P2; P<0.0001) (Table 2). 
The mean measurable period and standard deviation were 13.2±18.5 weeks in the control 






   It was unclear whether the insertion of the alternative bone material could affect bone 
healing and the recovery of the infra-orbital nerve in the gap between the segments in Le 
Fort I osteotomy with absorbable plate fixation. This study was performed to evaluate the 
combined use of an absorbable plate system and bone substitute material from the view of 
morphological change in maxillary bone healing and sensory disturbance of the upper lip.  
Factors that have been implicated for instability after Le Fort I osteotomies include 
presurgical orthodontics, inadequate mobilization, inappropriate or lack of grafting, 
increased masticatory forces, inadequate methods of fixation, type and amount of 
movement, soft tissue tension, and presence of a cleft. Various fixation techniques have 
been used for maxillary stabilization including trans-osseous and suspension wires, 
intraoral skeletal fixation appliances, and bone plating (Ueki et al., 2007; Marşan et al., 
2009; Mavili et al., 2009; Kretschmer et al., 2010). Post-operatively, the maxilla appears to 
be healed and in a stable position on clinical assessment.  
With regard to animal studies, Bell et al. have reported primate studies that provide biologic 
insight into the bone healing and revascularization processes that accompany maxillary 
osteotomies (Bell, 1969; Bell & Levy, 1971; Bell et al., 1975). These studies have indicated 
that osseous union of osteotomized sites occurs as early as six weeks postoperative. 
However, there have been few histologic studies on human tissues to verify the type of 
repair that is initiated. A previous study by Compton et al. (1984) indicated that the area 
between the segments healed with mature compact bone, from the evaluation of punch 
biopsy at the osteotomy site of five patients after Le Fort I osteotomy. However, the period 
of biopsy was not constant, ranged from 17 to 30 months, and there was no detailed 
description of the site that was taken for biopsy. It was unclear whether all the sites on the 
osteotomy line could induce new bone. 
In Le Fort I osteotomy, incomplete ossification of osteosynthesis is one of the major 
problems (Proffit et al., 2003). If the size of the defect between the advanced inferior 
maxillary segment and the superior segment exceeds 3mm at the levels of the piriform rim 
and zygomaticomaxillary junction following Le Fort I osteotomy, use of a bone graft can 
become necessary for stabilization. Furthermore, bone recovery would be inadequate if 
there is a defect of more than 3 mm between the segments along the line of osteosynthesis. 
The line of osteosynthesis would involve fibrous tissue rather than osseous tissue. In this 
instance, resistance to relapse would be via this fibrous tissue and the initial plate and screw 
rather than a robust osseous tissue (Holmes et al., 1988; Proffit et al., 2003).  However, 
there has been no well-controlled study in which the maxilla is advanced to a large distance 
with and without bone grafting. 
The resorbable bone fixation devices have been developed for use in orthopedic or 
cranio-facial, oral and maxillofacial or plastic and reconstructive surgeries (Shikinami & 
Okuno, 1999; Shikinami & Okuno, 2001; Shikinami et al., 2005). These devices are made 
from composites of uncalcined and unsintered hydroxyapatite (u-HA) particles and 
poly-L-lacted (PLLA), and they are produced by a forging process, which is a unique 
compression molding, and machining treatment. They have a modulus of elasticity close to 
that of natural cortical bone, and they can retain a high strength during the period required 
for bone healing. They can also show optimal degradation and resorption behaviour, 
osteoconductivity, and bone bonding capability. In this study, the absorbable plate 
remained after 1 year as confirmed by CT imaging, although characteristic material 
changes were not observed.   
Monma et al. (1988) have originally developed a self-setting cement-type calcium 
phosphate material consisting of α-TCP, dicalcium phosphate dibasic (DCPD) and 
tetracalcium phosphate monoxide (TeCP). According to their extensive studies, this 
cement-type material could be refined, demonstrating better biocompatibility and direct 
integration to bone without any participation of peripheral soft tissue (Kurashina et 
al.,1997a,b; Yamamoto et al., 1998; Yuan et al., 2000).  As it is free of infiltration over 
time of residual monomers of methacrylate resin, which has long been used for orthopedic 
treatment, this self-setting cement came to be rapidly targeted for clinical use in Japan. 
The combined use of segmental fixation with an absorbable plate system and filling in the 
space between the segments were assumed to be clinically necessary. Prior to this clinical 
study, a previous study using rabbit suggested that the use of an absorbable plate (Super 
FIXSORB®-MX) in combination with Biopex® was useful and both Super 
FIXSORB®-MX and Biopex® could provide adequate bone regeneration and maintain 
strength and stability in the surgical bone space (Okabe et al., 2010).  
In fact, it was difficult to evaluate the healing in the segmental gap using the absorbable 
plate and the alternative bone material. When the 3DCT reconstruction was performed and 
evaluated, the threshold of the CT value was very important to judge whether it was that of 
matured bone or soft tissue. Lettry et al. (2003) reported that the CT values of mandibular 
cortical bones in 10 cadavers ranged from 976 HU to 1478 HU, with a mean of 1183.9 HU 
(SD 112.1). However, there is no report regarding the anterior and lateral walls of the 
maxillary bone that will allow CT values to be determined as over 1200 HU according to 
our previous report (Ueki et al, 2011a). Furthermore, the CT value of setting Biopex® was 
also unclear. After the CT value was changed repeatedly in the image software, the 
threshold of the CT value measurable of Biopex® inserted at the maxilla was standard as 
over 2200.  This value was clearly higher than the surrounding cortical bone at the anterior 
part of the maxilla so that the mother bone could be detected. Although immature bone 
tissue may not be detected in this study, this determination of the CT value was considered 
acceptable, because the detection of just hard bone tissue to keep the skeletal strength and 
stability was necessary for this study.  
In this study, the areas of bone defect after 1 year were significantly smaller than those 
immediately after surgery in the right and left anterior walls of the maxilla, similarly to in 
the previous study.  The previous study suggested that the complete bone healing was not 
associated with the movement of the maxilla and bony contact between segments.  
A significant decrease in the square of the Biopex® after 1 year suggested that Biopex® is 
likely absorbed. Although it was difficult to judge the segmentation of new bone and the 
Biopex® accurately, the remnant Biopex® could be identified as a block over 2200 HU.  
Actually, the small particles surrounding the remnant Biopex® could not be detected. 
However, the surroundings of the blocks of Biopex that decreased the square were filled 
with bone tissue after 1 year in all cases. If the Biopex® could not be replaced with new 
bone over 1200 HU, the soft tissue or bone tissue under 1200 HU was detected as the bone 
defect.   In all sides of the Biopex® group, the bone defect at the anterior part of the 
maxilla was not seen after 1 year. In contrast, in 34/46 sides of the control group, the bone 
defect (over 1200HU) was observed after 1year.  
The presence of remnant Biopex® after 1 year also suggested that the resorption of the 
Biopex® was comparatively slow. In the study of Hao et al. (2004) using rabbit femoral 
cortical bone, a range of osteoclasts accumulated on the surface of the Biopex®, whilst 
many osteoblasts were localized on the surface opposing the Biopex® from days 5 to 10. 
However, remnants of the Biopex® particles were present in the new bone with a profile of 
compact bone on days 30 and 40. The Biopex® was very hard such that the osteoclasts 
could not resorb it rapidly. In orthognathic surgery, use of Biopex can compensate the 
strength and rigidity between segments from the early post-surgery period. It was 
considered that the slow replacement of the Biopex® could also contribute to maintaining 
the strength of the mandible after surgery.  
On the other hand, disturbance of the sensitivity of the upper lip should be considered after 
Le Fort I osteotomy with some materials. In Le Fort I osteotomy, the three superior alveolar 
nerves are transected as part of the osteotomy, and the terminal labial branches of the 
infraorbital nerve are transected as part of the mucosal incision. After the infraorbital nerve 
emerges from the infraorbital foramen, it may be subjected either to direct laceration or to 
traction injury, as a result of the forceful use of retractors during the operation (Posnic et al., 
1994). 
TSEP, a somatosensory evoked potential of the peripheral nerves has been used previously 
to investigate the causal factors of trigeminal sensory hypoesthesia that occurs after SSRO 
(Nakagawa et al., 1997; Nakagawa et al., 2001; Nakagawa et al., 2003; Hashiba et al., 
2007; Hashiba et al., 2008). This method is highly objective and reliable as the potential 
changes of cerebral origin can be detected on the scalp in human subjects following 
electrical stimulation of the peripheral nerves. SEP data is collected directly from the 
electroencephalography derived from the cerebral cortex making data of TSEP more 
objective and reliable. Thus, differences between objective and subjective assessments may 
occur. Furthermore, there may also be differences between the actual return of sensation 
and registration of nerve conduction. Advancements in the field of neurophysiology have 
revealed posttraumatic changes in the central nervous system. Functional disturbance in the 
central nervous system after peripheral nerve injury is known as central sensitization 
(Coderre et al., 1993; McQuay et al., 1994). In this study, the result of data using TSEP 
was considered as valid and reliable. 
The previous study objectively shows that hypoesthesia occurs in the upper lip following 
Le Fort I osteotomy with TSEP. The measurable period (i.e., when the TSEP wave appears 
firstly after surgery) of the upper lip following Le Fort I osteotomy tended to be longer than 
that of the lower lip in the patients who underwent SSRO and IVRO. Furthermore, 
temporary hypoaesthesia of the upper lip after Le Fort I osteotomy could not be avoided, 
however, the osteotomy line, plate/screw position and pterygoid plate fracture in Le Fort I 
osteotomy did not affect the recovery period of the upper lip hypoaesthesia with TSEP. 
When alternative materials are used at the area between the maxillary segments, it is 
unclear whether use of such material can affect the recovery period of upper lip 
hypoesthesia (Ueki et al., 2007; Ueki et al., 2008).  
In this study, age and gender were not correlated to the recovery period of TSEP. In both 
groups, post-operative latency period was significantly longer than the preoperative value. 
The measurable period was the first peak time of the TSEP wave that could be identified 
post-operatively, and the upper lip seemed less sensitive in this time. Interestingly, this 
tendency was different from the result of recovery period of lower lip hypoesthesia after 
SSRO with TSEP reported previously (Hashibaet al.,2007). However, there was no 
significant difference between the two groups regarding the recovery period of upper lip 
hypoesthesia postoperatively, in this study. In the previous study, temporary hypoaesthesia 
of upper lip after Le Fort I osteotomy could not be avoided, however, the osteotomy line, 
plate/screw position and pterygoid plate fracture in Le Fort I osteotomy did not affect the 
recovery period of upper lip hypoaesthesia with TSEP (Ueki et al., 2008).  Similarly, this 
study suggested that use of the Biopex® did not affect the recovery period of upper lip 




This study suggested that inserting Biopex® in the gap between the maxillary segments 
was useful for new bone formation and it did not prevent the recovery of upper lip 
hypoesthesia after Le Fort I osteotomy with absorbable plate fixation. 
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Fig.1 Measurements of the areas of bone defects on 3DCT image. A: immediately after 
surgery, B: 1 year after surgery. Red area shows a bone defect. uHA/PLLA plates were 
recognized. In this case, complete bone healing was not found after 1 year. 
 
Fig. 2 Measurements of the area of Biopex® on 3DCT image. A: immediately after surgery, 
B: 1 year after surgery. Red area shows the Biopex®. Yellow area shows a 3D 
reconstruction image over 2200 HU and the transparent blue area shows a 3D 
reconstruction image from 1200 HU to 2200 HU. uHA/PLLA plates were recognized. 
 
Fig. 3 A: The area of defects between segments. Error bars show the standard deviation. * 
indicates a significant difference at P<0.05. B: the area of Biopex®. Error bars show the 
standard deviation. * indicates a significant difference at P<0.05. 
 
Table 1. A: The area of defects between segments. SD indicates standard deviation. B: the 
area of Biopex®. SD indicates standard deviation. 
 




































(mm2) Mean SD Mean SD
Area of bone defect Right 28.3 15.8 16.5 16.3
Left 19.7 15.5 12.2 13.5
1week 1year
(mm2) Mean SD Mean SD
Area of Biopex® Right 127.0 70.2 105.2 62.0
Left 104.9 50.3 85.6 44.0
Latency period (Seconds) Ｎ1 Ｐ1 Ｎ2 Ｐ2 Measurable period (weeks)
Mean SD Mean SD Mean SD Mean SD Mean SD
Biopex® group Pre-operation 13.7 1.3 17.8 1.5 27.3 2.2 37.2 2.0
Post-operation 15.6 1.6 20.1 2.1 29.8 3.0 39.5 3.4 14.5 17.9
Control group Pre-operation 14.5 1.6 18.5 1.6 28.3 2.3 37.7 2.3
Post-operation 15.4 1.8 19.5 2.0 29.2 2.1 38.4 2.5 13.2 18.5
Table. 2
